BOPA launches first Advanced Clinical Update in Oncology Course

BOPA’s first Advanced Clinical Update in Oncology Course on Monday 30th April was a great success! We had 58 people attend at the Royal Marsden Hospital in central London. The day was kick stated with an interactive session on statistics, followed by some practical hints and tips for successful implementation of biosimilars. We then heard about experiences from an immunotherapy nurse/pharmacist led clinic, showcasing fantastic multi-professional working. The day was then wrapped up by two breakout sessions providing clinical updates in solid tumours and haemato-oncology. For those of you not able to attend…don’t worry you’ll soon be able to access this great content via the BOPA website as we filmed the whole day!! We are currently processing the footage to turn it into new digital content, something we will be doing more of in future to increase the reach of our educational events. So watch this space…. exciting times ahead!!!

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article